Avanos Medical (AVNS)
(Delayed Data from NYSE)
$22.80 USD
+0.15 (0.66%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $22.81 +0.01 (0.04%) 6:38 PM ET
1-Strong Buy of 5 1
B Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$22.80 USD
+0.15 (0.66%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $22.81 +0.01 (0.04%) 6:38 PM ET
1-Strong Buy of 5 1
B Value D Growth C Momentum C VGM
Zacks News
Can Tenet Healthcare (THC) Post Q1 Earnings Beat on Low Costs?
by Zacks Equity Research
Tenet Healthcare's (THC) first-quarter 2022 results are likely to reflect an improvement in adjusted admissions and outpatient admissions.
Is Avanos Medical (AVNS) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Avanos Medical (AVNS) and Axcella Health Inc. (AXLA) have performed compared to their sector so far this year.
Philips' (PHG) Lung Suite 3D Imaging Solution Gains Traction
by Zacks Equity Research
Philips' (PHG) innovative lung cancer diagnosis and treatment solution, Philips Lung Suite, is witnessing rapid adoption by clinical partners globally
Philips (PHG) Ties Up With Nuvo Group to Boost Maternal Care
by Zacks Equity Research
Philips (PHG) collaborates with Nuvo to develop maternity care services with digital solutions and eco-system building in rural areas
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
New Strong Buy Stocks for March 11th
by Zacks Equity Research
ABM, AVNS, ASIX, AA, and ESEA have been added to the Zacks Rank #1 (Strong Buy) List on March 11, 2022.
Does Avanos Medical (AVNS) Have the Potential to Rally 26% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Avanos Medical (AVNS) points to a 26.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Avanos Medical (AVNS) Q4 Earnings, Revenues Top Estimates
by Zacks Equity Research
Avanos Medical's (AVNS) fourth-quarter 2021 results gain from strength in the chronic care segment.
Avanos Medical (AVNS) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Avanos Medical (AVNS) delivered earnings and revenue surprises of 15% and 1.63%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical (AVNS) Earnings Expected to Grow: What to Know Ahead of Q4 Release
by Zacks Equity Research
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for January 24th
by Zacks Equity Research
AGNC, AVNS, and SQ have been added to the Zacks Rank #5 (Strong Sell) List on January 24, 2022
Intuitive Surgical, Inc. (ISRG) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of 1.56% and 0.76%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for January 19th
by Zacks Equity Research
ONEM, ALXO, and AVNS have been added to the Zacks Rank #5 (Strong Sell) List on January 19, 2022
Avanos Medical (AVNS) Set to Acquire OrthogenRx for $160M
by Zacks Equity Research
Avanos Medical's (AVNS) deal to acquire OrthogenRx is likely to boost the company's chronic pain portfolio.
Avanos Medical's (AVNS) App to Support Pain Management Process
by Zacks Equity Research
Avanos Medical's (AVNS) new solution to help healthcare providers with respect to patients' overall pain management process.
Avanos Medical (AVNS) Down 17.6% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Avanos Medical (AVNS) Q3 Earnings Lag Estimates, Revenues Top
by Zacks Equity Research
Avanos Medical's (AVNS) third-quarter 2021 results gains from strength in the Pain Management segment.
Avanos Medical (AVNS) Q3 Earnings Lag Estimates
by Zacks Equity Research
Avanos Medical (AVNS) delivered earnings and revenue surprises of -7.41% and 0.11%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical (AVNS) to Report Q3 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Avanos Medical (AVNS) Down 2.2% Since Last Earnings Report?
by Zacks Equity Research
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Avanos Medical (AVNS) Q2 Earnings Lag Estimates, Revenues Top
by Zacks Equity Research
Avanos Medical's (AVNS) second-quarter 2021 results gains from strength in Pain Management segment.
What's in Store for Senseonics Holdings' (SENS) Q2 Earnings?
by Zacks Equity Research
Senseonics Holdings' (SENS) second-quarter results are likely to gain from higher sales outside the United States.
DENTSPLY SIRONA (XRAY) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
DENTSPLY SIRONA's (XRAY) second-quarter results are likely to reflect strong segmental performance.
Avanos Medical (AVNS) Q2 Earnings Miss Estimates
by Zacks Equity Research
Avanos Medical (AVNS) delivered earnings and revenue surprises of -8.70% and 2.36%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Cardinal Health (CAH) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Cardinal Health's (CAH) fiscal fourth-quarter results are likely to reflect solid performance in Pharmaceutical segment.